Home MarketSyngene International Ltd.

Syngene International Ltd. Stock Info: As on 2018-05-24 15:48:35

Nse

605.85

-0.10(-0.02%)
Change%
52 Week Range
430.10
11.00
700.00
25.00
Open609.35
Day's Range484.76 - 727.14
Value Traded (in ₹ Cr.) 8.09

Bse

605.00

-2.50(-0.41%)
Change %
52 Week Range
430.00
11.00
699.80
25.00
Open618.95
Day's Range486.00 - 729.00
Value Traded (in ₹ Cr.) 0.19

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 148,890,611.00 74.45%
Mutual Funds/UTI 4,087,732.00 2.04%
FII 31,180,170.00 15.59%
Employee 0.00 0.00%
Public 9,146,686.00 4.57%
Government 0.00 0.00%
Others 2,811,968.00 1.41%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 8.70
Basic EPS (Rs.) 14.71
Cash EPS 20.08
BVPerShare Excl 70.66
Operating Revenue 60.05
PBDITPerShare 23.91
Dividend 1.00
NPPerShare 14.37
Current Ratio 2.54
Quick Ratio 2.49
PriceToBV 7.39
Earnings 0.02
PBDIT Margin 39.82
PBT Margin 28.85
NP Margin 23.92
Return On Assets 10.35
Retention Ratios 0.00
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 1,271.60
Total Expenses 925.10
EBITDA 478.30
PBT 346.50
PAT 287.30
Net Income 287.30
More
Parameter Mar-18 (₹ Cr.) 6M % change
Total Income 825.00
Total Expenses 611.10
EBITDA 144.70
PBT 201.70
PAT 166.20
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 200.00
Net worth 1,413.10
Investments 540.40
Total Liability 2,773.80
Total debt 787.00
Net block 985.30
Total Assets 2,773.80
Parameter Mar-17 (₹ Cr.) 6M % change
Total share capital 199.20
Net worth 1,052.80
Investments 276.40
Total Liability 2,389.50
Total debt 891.00
Net block 817.00
Total Assets 2,389.50
Company Curr Price Prev. Close Change% W's Low/High

Adani Ports & Special Economic Zone Ltd.

371.25 374.25 -0.8
373.5405.5

Banaras Beads Ltd.

53.25 54.45 -2.2
5257

Binani Industries Ltd.

87.85 88.3 -0.51
87.196

Delta Corp Ltd.

231.3 227.9 1.49
224.6271

Dredging Corporation Of India Ltd.

556.85 558.6 -0.31
551604.9

Future Consumer Ltd.

53.9 54.5 -1.1
52.759.7

Gateway Distriparks Ltd.

165.95 167.7 -1.04
164177.55
Company Curr Price Prev. Close Change% W's Low/High

Adani Ports & Special Economic Zone Ltd.

372 373.5 -0.4
372.75418

Alpha Hi-Tech Fuel Ltd.

0.87 0.91 -4.39
0.870.87

Anil Ltd.

28.9 30.4 -4.93
28.928.9

Bagalkot Udyog Ltd.

23.9 25.15 -4.97
23.923.9

Banaras Beads Ltd.

53.45 55.2 -3.17
50.258.75

Binani Industries Ltd.

87.6 88.2 -0.68
8898.8

Brahmanand Himghar Ltd.

4.08 4.29 -4.9
4.084.08
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 397.70
Cash from investing activities -469.10
Cash from financing activities -80.80
Net change in cash -152.80

Stock Held By Mutual Fund Schemes

M Venkatesh appointed MRPL MD

M Venkatesh has been appointed as the Managing Director of Mangalore Refineries and Petrochemicals Limited (MRPL), an order issued by the Personnel Ministry said today. Vekatesh is at present Director (Refineries) in the MRPL, a subsidiary of the Oil and Natural Gas Corporation Limited (ONGC) He has been appointed to the post for a period of five years with effect from the date of his assumption of charge of the post on or after June 1, 2018, or till the date of his superannuation, the order said.

24-05-2018 11:42

TCS expands operations in Florida as part of Transamerica deal

India's largest IT services firm TCS today said it has expanded operations in Florida, US, with over 430 employees joining the company as part of its deal with Transamerica. In January, Tata Consultancy Services (TCS) had signed an over USD 2 billion deal with Transamerica to administer the latter's life insurance, annuity, supplemental health insurance, and workplace voluntary benefits products. It covered managing administration of more than 10 million policies. More than 430 former Transamerica employees now work for TCS at this new St Petersburg facility (in Florida) as part of recruiting and investing in more than 2,200 Transamerica jobs across the US in multiple locations, the Indian software services giant said in a statement. TCS will occupy several floors of Transamerica's building at 570 Carillon Parkway in St Petersburg, as part of a multi-year agreement with Transamerica... The St Petersburg office is a new US business centre for TCS, adding to the over 1,000 employees already serving American businesses throughout the state, it added. TCS said it has invested nearly USD 3 billion in the US over the past three years and has been among the top two IT services job creators in the country. TCS is a leading industry employer in the US, striving to help American companies like Transamerica to digitally transform their business and capitalise on rapidly evolving customer demands, TCS President and Global Head (Banking, Financial Services and Insurance Platforms) Suresh Muthuswami said. We look forward to partnering with St Petersburg's city, state and local organizations to further build upon our business and community impact, he added. The company said it has made tremendous community impact in Florida over past several years.

24-05-2018 11:16

Kotak India Growth Fund Series 4 - Direct Plan: change in investment factsheets for April

Kotak India Growth Fund Series 4 - Direct Plan has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.89 for Growth, while 52-Week High and Low ranges were Rs 10.35 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 - Direct Plan is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

Kotak India Growth Fund Series 4: change in investment factsheets for April

Kotak India Growth Fund Series 4 has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.88 for Growth, while 52-Week High and Low ranges were Rs 10.34 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

BLS International to assist Sopra Steria on UK visa renewals

Visa service provider BLS International today said theUnited Kingdom Visas and Immigration (UKVI) has awarded Sopra Steria a new contract to enable visa renewals for those individuals who are already in the UK. BLS International will support Sopra Steria and UKVI, a division of the UK Home Office responsible for deciding who can visit and stay within the UK, by establishing and delivering some of the key add value services under the contract, it said in a release. BLS International claims to handle about 12 million visa applications annually across the globe at present. Meanwhile, shares of the company were trading at Rs 172.55 apiece, up 1 per cent from the previous close at 10:50 hours on BSE.

24-05-2018 10:51

Syngene Internationa - Updates

Syngene International Limited has informed the Exchange regarding ''Completion of Sale of shares of the Company by the Promoter ?Biocon Limited? in the Open Market for achieving Minimum Public Shareholding''.

17-May-2018 05:55 PM

Syngene Internationa - Completion Of Sale Of Shares Of The Company By The Promoter 'Biocon Limited' In The Open Market For Ac

In continuation of our intimation letter dated May 15, 2018 on the above mentioned subject, we would like to inform you that Biocon Limited, the promoter of the Company, on May 16, 2018, has sold 3,765,574 equity shares held in Syngene International Limited constituting 1.88% of Paid-up share capital through open market sale in accordance with SEBI's circular no. SEBI/HO/CFD/CMD/CIR/P/43/2018 dated February 22, 2018.

Consequent to the aforementioned open market sale, the Company has complied with the minimum public shareholding requirements as mandated under rules 19(2)(b) and 19A of the Securities Contracts (Regulation) Rules, 1957 ('the SCRR') read with regulation 38 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

17-May-2018 05:49 PM

Syngene Internationa - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst/Investor Meet

16-May-2018 03:30 PM

Syngene Internationa - Analysts/Institutional Investor Meet/Con. Call Updates

Syngene International Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

16-May-2018 03:26 PM

Syngene Internationa - Updates

Syngene International Limited has informed the Exchange regarding ''Sale of shares of the Company by the Promoter ?Biocon Limited? in the Open Market for achieving Minimum Public Shareholding''.

15-May-2018 07:06 PM

Syngene Internationa - Completion Of Sale Of Shares Of The Company By The Promoter 'Biocon Limited' In The Open Market For Ac

In continuation of our intimation letter dated May 15, 2018 on the above mentioned subject, we would like to inform you that Biocon Limited, the promoter of the Company, on May 16, 2018, has sold 3,765,574 equity shares held in Syngene International Limited constituting 1.88% of Paid-up share capital through open market sale in accordance with SEBI's circular no. SEBI/HO/CFD/CMD/CIR/P/43/2018 dated February 22, 2018.

Consequent to the aforementioned open market sale, the Company has complied with the minimum public shareholding requirements as mandated under rules 19(2)(b) and 19A of the Securities Contracts (Regulation) Rules, 1957 ('the SCRR') read with regulation 38 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

17-May-2018 05:49 PM

Syngene Internationa - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst/Investor Meet

16-May-2018 03:30 PM

Syngene Internationa - Sale Of Shares Of The Company By The Promoter 'Biocon Limited' In The Open Market For Achieving Minimu

Sale of shares of the Company by the Promoter 'Biocon Limited' in the Open Market for achieving Minimum Public Shareholding

15-May-2018 07:05 PM

Corporate Details

About Management

The Company was incorporated as Syngene International Private Limited on November 18, 1993 at Bengaluru, Karnataka as a private limited company under the Companies Act, 1956. Pursuant to a special resolution of the shareholders dated March 26, 2007, the Company was converted into a public limited company and the name of the Company was changed to Syngene International Limited. A fresh certificate of incorporation consequent upon conversion to public limited company was issued on April 19, 2007. the Company was promoted by Kiran Mazumdar Shaw, a promoter of Biocon. On March 30, 2002, 99.9 percent of the Equity Shares of the Company were transferred to Biocon and as a result, the Company became the subsidiary of Biocon. Biocon has since been the Promoter of the Company.The details of changes in the registered office of the Company are given below: From 20th KM, Hosur Road, Electronics City P.O, Bengaluru 560 100, Karnataka, India to Biocon Special Economic Zone, Biocon Park, Plot No. 2 and 3, Bommasandra Industrial Area IV Phase, Jigani Link Road, Bommasandra, Bengaluru 560 099, Karnataka, India. Major events and milestones of the Company : 1994 -Initiated operations as a CRO with services in chemistry and biology 1998 -Granted 100% Export Oriented Unit (EOU) status by the Government of India 1999 -First operational expansion in R&D by way of expansion of lab space to over 23,000 sq. ft. 2000 -CIL was incorporated as a 100% subsidiary of Biocon to provide clinical research services to domestic and multinational companies 2001 -Forayed into chemical development with a dedicated manufacturing facility 2003 -Moved to Biocon Park, a 90 acre biopharmaceutical SEZ with operations spread over 65,000 sq. ft. 2007 -Bristol-Myers Squibb and the Company signed the first long term contract to set up the first dedicated R&D centre -Expansion of research facilities at Biocon SEZ to 148,000 sq. ft. -Crossed an annual turnover of over `1,000 million in Financial Year 2007 2009 -Dupont Crop Protection and the Company extended a partnership for R&D services -Expansion of manufacturing services with a new plant which is cGMP compliant -Initiated operations in safety assessment and large molecules development services 2010 -Acceptance of the clinical and bio-analytical facilities of CIL by the Department of Health & Human Services, FDA -Initiated operations in formulation development 2011 -Endo Pharmaceuticals and the Company collaborated to develop novel biological therapeutic molecules against cancer 2012 -Abbott and the Company collaborated to establish Abbott's nutrition research and development centre in India and the second R&D centre -Certification of the clinical facilities by ANVISA -Acquired 100% stake in Clinigene International Limited from Biocon 2013 -Crossed an annual turnover of over `5,000 million in Financial Year 2013 -Baxter International Inc. collaborated with the Company to establish the `Baxter Global Research Center', the third dedicated R&D centre -Acceptance of the control testing laboratory by the Department of Health & Human Services, FDA 2014 -Bristol-Myers Squibb and the Company extend collaboration for its dedicated R&D centre till 2020 -Acceptance of the API manufacturing facility by the Department of Health & Human Services, FDA -Established a 75,000 sq.ft centre to provide stability and analytical services 2015 -CIL was amalgamated with the Company Awards, Recognitions and Accreditations : 2009 - Bangalore Bio, Bio Excellence Award - Biotech Services Sector - Best BioServices company of the year by Biospectrum 2012 - ISO 9001:2008 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - AAALAC accreditation for conforming to the "Guide for the Care and Use of Laboratory Animals and the Committee for the Purpose of Control and Supervision of Experiments on Animals guidelines" 2013 - Bioservices - ABLE Tenth Anniversary Award - Outstanding contribution to Bioservices - Diamond sponsor recognition by the Association of Scientists of Indian Origin of the Society of Toxicology 2014 - ISO 14001:2004 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - BS OHSAS 18001:2007 for contract research in drug discovery and contract manufacturing of biopharmaceuticals - Silver EDGE Award - EHS best practices award by CII - SAP Ace Award for special recognition for complex SAP implementation - Level I Laboratory certification issued by the NGSP to Clinigene International Limited 2015 - Accreditation by the College of American Pathologists in relation to their laboratory accreditation program - Bangalore India Bio - Bio Excellence Award for outstanding contribution to the Biotech services sector - ISO 15189:2007 in the field of medical testing 2017 -Herbalife Nutrition Partners with Syngene to Establish Nutrition Research and Development Lab in India. -"Syngene International Announces Broadening of Research Collaboration with Amgen Inc." expands Dedicated R&D Center. -"Bristol-Myers Squibb and Syngene International Expand Ongoing Research Collaboration.".

Registered Office

113-C - 2, Bommasandra Industrial Area, Attibele Hobli, Anekal Taluk,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.